GeneticsNewborn ScreeningShortly after birth, a blood sample is taken from a newborn to
screen for diseases such as
phenylketonuria (PKU) and congenital
hypothyroidism. This type of testing is important
because treatment is available to improve the health of the child. Newborn
screening is required in the United States, but states vary on which tests they
offer. Examples of tests used for newborn screening include: - Phenylketonuria
(PKU) screen, which measures the amount of phenylalanine in a baby's
blood. Babies found to have PKU should be put on a special low-protein diet to
prevent mental retardation.
- Newborn screening for
cystic fibrosis. Levels of immunoreactive trypsinogen (IRT), a digestive
enzyme, are measured from a blood sample. Abnormally high levels of IRT suggest
cystic fibrosis, although further testing is needed to confirm the
diagnosis.
- Hemoglobin test, which tests for types
of
hemoglobin in a baby's blood that may indicate
sickle cell trait or
sickle cell disease. Babies who have sickle cell
disease need special medical care throughout their lives to treat the variety
of problems that can be caused by the illness.
Other tests, such as newborn
hearing tests, can tell whether a baby may need future
hearing services or genetic testing. Approximately 50% of cases of newborn
hearing loss are caused by genetic factors.4
Go to previous section | Go to top of page | Go to next section |
| | Author: | Maria G. Essig, MS, ELS | Last Updated: November 20, 2007 | | Medical Review: | Anne C. Poinier, MD - Internal Medicine Siobhan M. Dolan, MD, MPH - Reproductive Genetics | © 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
| 
| |
| |